BRPI0607280A2 - método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento - Google Patents

método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento

Info

Publication number
BRPI0607280A2
BRPI0607280A2 BRPI0607280-1A BRPI0607280A BRPI0607280A2 BR PI0607280 A2 BRPI0607280 A2 BR PI0607280A2 BR PI0607280 A BRPI0607280 A BR PI0607280A BR PI0607280 A2 BRPI0607280 A2 BR PI0607280A2
Authority
BR
Brazil
Prior art keywords
treatment
patient
adhesive capsulitis
prevention
need
Prior art date
Application number
BRPI0607280-1A
Other languages
English (en)
Inventor
Marie Badalamente
Original Assignee
Advance Biofactures Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance Biofactures Corp filed Critical Advance Biofactures Corp
Publication of BRPI0607280A2 publication Critical patent/BRPI0607280A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24—Metalloendopeptidases (3.4.24)
    • C12Y304/24007—Interstitial collagenase (3.4.24.7), i.e. matrix metalloprotease 1 or MMP1

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

MéTODO DE TRATAMENTO OU PREVENçãO DE CAPSULITE ADESIVA EM PACIENTE COM NECESSIDADE DESSE TRATAMENTO. A invenção refere-se à descoberta de que injeções de colagenase são efetivas para a use de aderências colagenosas no ombro e tratar o distúrbio, capsulite adesiva. Dessa forma, a invenção refere-se aos métodos de tratamento ou prevenção de capsulite adesiva, ou ombro congelado, em um paciente com necessidade desse tratamento, o qual compreende injetar ou de outro modo distribuir uma quantidade efetiva de colagenase nas aderências colagenosas no ombro. A invenção também se refere ao uso de colagenase na manufatura de um medicamento para tratar capsulite adesiva.
BRPI0607280-1A 2005-01-21 2006-01-19 método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento BRPI0607280A2 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US64577205P 2005-01-21 2005-01-21
US67744005P 2005-05-03 2005-05-03
US71947005P 2005-09-22 2005-09-22
PCT/US2006/001980 WO2006078870A2 (en) 2005-01-21 2006-01-19 Methods for treating adhesive capsulitis

Publications (1)

Publication Number Publication Date
BRPI0607280A2 true BRPI0607280A2 (pt) 2009-08-25

Family

ID=36692898

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607280-1A BRPI0607280A2 (pt) 2005-01-21 2006-01-19 método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento

Country Status (22)

Country Link
US (5) US20060204488A1 (pt)
EP (2) EP2977058A1 (pt)
JP (1) JP4967081B2 (pt)
KR (2) KR100989267B1 (pt)
CN (1) CN101107006B (pt)
AU (1) AU2006206393B2 (pt)
BR (1) BRPI0607280A2 (pt)
CA (1) CA2593038C (pt)
CY (1) CY1120193T1 (pt)
DK (1) DK1846022T3 (pt)
ES (1) ES2548516T3 (pt)
HK (1) HK1221143A1 (pt)
HR (1) HRP20150889T1 (pt)
HU (1) HUE027236T2 (pt)
ME (1) ME02344B (pt)
MX (1) MX2007008764A (pt)
NZ (1) NZ556160A (pt)
PL (1) PL1846022T3 (pt)
PT (1) PT1846022E (pt)
RS (1) RS54265B1 (pt)
SI (1) SI1846022T1 (pt)
WO (1) WO2006078870A2 (pt)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
US11879141B2 (en) 2012-01-12 2024-01-23 Endo Global Ventures Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6958150B2 (en) 1994-12-15 2005-10-25 Advance Biofactures Of Curacao, N.V. Reduction of adipose tissue
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) * 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US8383398B2 (en) * 2008-04-17 2013-02-26 Anaeropharma Science, Inc. Expression vector
AU2011322482B2 (en) * 2010-10-30 2017-03-23 Oxford University Innovation Limited Treatment for Dupuytren's disease
WO2013034416A1 (en) 2011-09-09 2013-03-14 Unilever N.V. Antimicrobial method and composition
WO2014066622A2 (en) 2012-10-24 2014-05-01 The Research Foundation For The State University Of New York Use of collagenase to treat glaucoma
RU2745328C1 (ru) * 2020-05-24 2021-03-23 Федеральное государственное бюджетное учреждение «Федеральный центр травматологии, ортопедии и эндопротезирования» Министерства здравоохранения и социального развития РФ (г. Чебоксары) Способ лечения болевого синдрома при адгезивном капсулите

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524065A (en) * 1983-08-04 1985-06-18 Bio-Specifics N.V. Method for the prevention and treatment of scars with enzymes
DE4200080A1 (de) * 1992-01-03 1993-09-30 Reinmueller Johannes Pharmazeutische Zusammensetzung zur Wund-, Narben- und Keloidbehandlung
US5589171A (en) * 1994-08-22 1996-12-31 Advance Biofactures Of Curacao Treatment of Dupuytren's disease with collagenase
US5989888A (en) 1996-01-24 1999-11-23 Roche Diagnostics Corporation Purified mixture of collagenase I, collagenase II and two other proteases
US5830741A (en) 1996-12-06 1998-11-03 Boehringer Mannheim Corporation Composition for tissue dissociation containing collagenase I and II from clostridium histolyticum and a neutral protease
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease
US6060474A (en) 1998-11-05 2000-05-09 New York Society For The Relief Of The Ruptured And Crippled Maintaining The Hospital For Special Surgery Method for preventing scar tissue formation
US6022539A (en) 1999-06-03 2000-02-08 Advance Biofactures Of Curacao Amelioration of peyronie's disease
EP1433845A1 (en) 2002-12-23 2004-06-30 Georg-August-Universität Clostridium tetani collagenase and uses thereof
US20070224184A1 (en) 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7854929B2 (en) 2005-01-21 2010-12-21 The Research Foundation Of State University Of New York Method for treating lateral epicondylitis using collagenase

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11879141B2 (en) 2012-01-12 2024-01-23 Endo Global Ventures Nucleic acid molecules encoding clostridium histolyticum collagenase II and methods of producing the same
US11975054B2 (en) 2012-01-12 2024-05-07 Endo Global Ventures Nucleic acid molecules encoding clostridium histolyticum collagenase I and methods of producing the same
US12263209B2 (en) 2012-01-12 2025-04-01 Endo Biologics Limited Pharmaceutical compositions comprising collagenase I and collagenase II
US11123280B2 (en) 2017-03-01 2021-09-21 Endo Ventures Limited Method of assessing and treating cellulite
US11813347B2 (en) 2017-03-01 2023-11-14 Endo Ventures Limited Method of assessing and treating cellulite
US12403081B2 (en) 2017-03-01 2025-09-02 Endo Operations Limited Method of assessing and treating cellulite
US11473074B2 (en) 2017-03-28 2022-10-18 Endo Global Aesthetics Limited Method of producing collagenase
US12448615B2 (en) 2017-03-28 2025-10-21 Endo Operations Limited Method of purifying and isolating collagenase

Also Published As

Publication number Publication date
CA2593038A1 (en) 2006-07-27
EP1846022A4 (en) 2009-08-05
AU2006206393B2 (en) 2010-04-08
HK1221143A1 (en) 2017-05-26
HRP20150889T1 (hr) 2015-11-20
NZ556160A (en) 2009-11-27
RS54265B1 (sr) 2016-02-29
CY1120193T1 (el) 2018-12-12
CN101107006A (zh) 2008-01-16
AU2006206393A1 (en) 2006-07-27
PT1846022E (pt) 2015-09-03
SI1846022T1 (sl) 2016-01-29
US20090123454A1 (en) 2009-05-14
US20150174216A1 (en) 2015-06-25
US20060204488A1 (en) 2006-09-14
US20130330320A1 (en) 2013-12-12
HUE027236T2 (en) 2016-10-28
EP2977058A1 (en) 2016-01-27
KR100989267B1 (ko) 2010-10-20
KR20090130158A (ko) 2009-12-17
DK1846022T3 (en) 2015-08-24
US8323643B2 (en) 2012-12-04
EP1846022B1 (en) 2015-05-20
WO2006078870A2 (en) 2006-07-27
JP4967081B2 (ja) 2012-07-04
CA2593038C (en) 2015-03-17
ES2548516T3 (es) 2015-10-19
PL1846022T3 (pl) 2016-06-30
EP1846022A2 (en) 2007-10-24
KR20070116587A (ko) 2007-12-10
US20160354450A1 (en) 2016-12-08
WO2006078870A3 (en) 2006-09-14
ME02344B (me) 2016-06-20
CN101107006B (zh) 2013-09-11
MX2007008764A (es) 2007-10-19
HK1109592A1 (en) 2008-06-13
JP2008528498A (ja) 2008-07-31
HK1115295A1 (en) 2008-11-28

Similar Documents

Publication Publication Date Title
BRPI0607280A2 (pt) método de tratamento ou prevenção de capsulite adesiva em paciente com necessidade desse tratamento
BR0310099A (pt) método para tratar dislipidemia ou uma doença associada com a dislipidemia
BR112017028194A2 (pt) moduladores de diaciglicerol aciltransferase 2 (dgat2)
BRPI0922301A2 (pt) combinações de inibidor de hsp90
NO20023473D0 (no) Sammensetninger for levering av en kortisol antagonist
BR112015009948A8 (pt) Antagonistas de ativina-actrii, usos dos mesmos para tratamento de doenças ósseas e outros distúrbios e método para monitorar a eficácia do tratamento ou prevenção de uma doença óssea e outros distúrbios
BRPI0606902A2 (pt) composto; método para o tratamento de uma doença ou distúrbio associado a atividade excessiva de bace em um paciente que dele necessite; método para modular a atividade de bace; composição farmacêutica
CO2021004141A2 (es) Moduladores de la expresión de pnpla3
WO2008063157A3 (en) A nanoparticle-based anticoagulant
CO6300826A2 (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
GT200800151A (es) Inhibidores de 11-beta-hsd1
BRPI0418384A (pt) composições farmacêuticas e métodos referentes à inibição de adesões fibrosas utilizando diversos agentes
ECSP20082339A (es) Moduladores de la expresión de apol1
BRPI0908635A8 (pt) composto, composição farmacêutica e método de tratamento de câncer
DK2029184T3 (da) Injicerbar fibrinsammensætning til knogleforstærkning
BR112012006468A2 (pt) métodos de tratamento de inflamação
BRPI0516680A (pt) injeção de selante de fibrina usando componentes reconstituìdos em aplicações espinais
CR20190471A (es) Moduladores de la expresión de pcsk9
CO2018004684A2 (es) Métodos para tratar la epilepsia
BR112014019399A2 (pt) métodos de tratamento da fibrose
WO2008090287A3 (fr) Utilisation d'au moins une neurotoxine botulique pour traiter la douleur induite par les traitements therapeutiques du virus du sida
BRPI0508254A (pt) métodos e composições para o tratamento ou prevenção de distúrbios psiquiátricos com inibidores de cox-2 sozinhos e em combinação com agentes antidepressivos
MX387658B (es) Métodos para tratar y/o prevenir queratosis actínica.
BRPI0916885B8 (pt) composição farmacêutica
CL2021000107A1 (es) Métodos de tratamiento de hfpef empleando dapagliflozina y composiciones que comprenden la misma

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal: appeal against refusal